10-year analysis of the ATAC trial: Wrong conclusion?

The Lancet Oncology

Volumn 12, Issue 3, 2011, Pages 216-217

  Tannock, Ian F ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; TAMOXIFEN;

ARTHRALGIA; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL (TOPIC); DISEASE FREE SURVIVAL; DRUG SAFETY; DRUG TOLERABILITY; DRUG WITHDRAWAL; EXPERIENCE; FRACTURE; HEART DISEASE; HUMAN; LETTER; OVERALL SURVIVAL; PATIENT COMPLIANCE; POSTMENOPAUSE; PRIORITY JOURNAL; SEXUAL DYSFUNCTION; SIDE EFFECT;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; FEMALE; HUMANS; NITRILES; POSTMENOPAUSE; TAMOXIFEN; TREATMENT OUTCOME; TRIAZOLES;

EID: 79952022144     PISSN: 14702045     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1470-2045(11)70049-3     Document Type: Letter

References (6)

1. Cuzick J, Sestak I, Baum M, et al. Effect of anastrozole and tamoxifen as adjuvant treatment for early-stage breast cancer: 10-year analysis of the ATAC trial. Lancet Oncol 2010, 11:1135-1141. for the ATAC/LATTE investigators.
2. Seruga B, Sterling L, Wang L, Tannock IF Reporting of serious adverse drug reactions of targeted cancer agents in pivotal phase III clinical trials. J Clin Oncol 2011, 29:174-185.
3. Highlights of prescribing information US Food and Drug Administration, (accessed Jan 05, 2011). http://www.accessdata.fda.gov/drugsatfda_docs/label/2009/020541s024s025lbl.pdf.
4. Amir E, Ocana A, Niraula S, Carlsson L, Seruga B. Toxicity of adjuvant endocrine therapy in postmenopausal breast cancer patients. 33rd Annual San Antonio Breast Cancer Symposium; San Antonio, TX, USA; Dec 8-12, 2010. S2-7 (abstr).
5. Monnier A Effects of adjuvant aromatase inhibitor therapy on lipid profiles. Expert Rev Anticancer Ther 2006, 6:1653-1662.
6. Hershman DL, Kushi LH, Shao T, et al. Early discontinuation and nonadherence to adjuvant hormonal therapy in a cohort of 8,769 early-stage breast cancer patients. J Clin Oncol 2010, 28:4120-4128.